Skip to main content
Clinical Trials/CTRI/2023/11/059780
CTRI/2023/11/059780Not yet recruitingPhase 2

Phase II non randomized open clinical evaluation of siddha medicine maha analuruva chooranam for the management of uthiravatha suronitham (Rheumatoid arthritis) - Nil

Dr Dharani P0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Age limit - 18 to 50 years
  • All genders
  • Morning stiffness more than 1 hour
  • Arthritis of more than 3 joints
  • Symmetrical arthritis
  • Patients positive for anti-CCP

Exclusion Criteria

  • Rheumatic fever
  • Psoriatic arthropathy
  • Gouty athritis
  • Any other serious systemic illness
  • Pregnant women and lactating mothers
  • Type 2 diabetes mellitus
  • The above criteria will be excluded clinically or based on the available medical reports.

Investigators

Sponsor
Dr Dharani P

Similar Trials